BioSpace News Archive

As Alzheimer’s Space Heats Up, Biopharma Leans In to Holistic Treatment

Acknowledging the limits of disease-modifying drugs like Leqembi and Kisunla, companies like Bristol Myers Squibb, Acadia, Otsuka and Lundbeck are renewing a decades-old search for symptomatic treatments, including in high-profile drugs like Cobenfy.

July 28, 2025

·

7 min read

·

Heather McKenzie

Mental health and problems with memory. Hands unraveling tangled red threads on head silhouette representing brain. Modern art collage.

Alzheimer’s disease

5 Alzheimer’s Readouts To Watch

These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up novel pathways of action to treat the memory-robbing illness.

July 28, 2025

·

8 min read

·

Tristan Manalac

Confused businessman stands in front of different arrows . The concept of hard choices.

Regulatory

Drug Pricing Just One Point of Confusion Over New FDA Vouchers

The Commissioner’s National Priority Vouchers aim to offer accelerated pathways to drugs that meet certain criteria, perhaps including a low price-tag. But the policy is vaguely defined and was announced without public input, going against the FDA’s own published practices, experts say.

July 28, 2025

·

4 min read

·

Dan Samorodnitsky

Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.

Schizophrenia

Atai-Partnered Schizophrenia Drug Flunks Mid-Stage Trial

Despite the failure of its Recognify-partnered inidascamine, Jefferies analysts do not expect a definitively negative stock impact on atai, given the company’s promising psychedelic pipeline.

July 28, 2025

·

2 min read

·

Tristan Manalac

A concept of unfair social prejudice. The miniature men and a magnifying glass.

Duchenne muscular dystrophy

Sarepta Denies Latest Patient Death is Elevidys-Linked as FDA Launches Probe

Brazilian authorities said the death was unlikely to have been caused by Elevidys and was instead more in line with severe infection exacerbated by immunosuppression.

July 28, 2025

·

2 min read

·

Tristan Manalac

Government

American Medical Association Urges RFK Jr. to Maintain Preventive Task Force

Health Secretary Robert F. Kennedy Jr. wants to remove all members of the USPSTF for being too “woke,” according to reporting by the Wall Street Journal. An HHS spokesperson, however, says no final decision has been made about the panel.

July 28, 2025

·

2 min read

·

Tristan Manalac

Collage of a man hand giving a one hundred dollar bill to a woman hand on a yellow circle on a beige scratched background

Deals

GSK Bets Up To $12B for Multi-Program Cancer Pact With Hengrui

The star of GSK’s Hengrui partnership is the COPD candidate HRS-9821, which will complement the pharma’s respiratory pipeline that’s anchored by the anti-asthma drug Nucala.

July 28, 2025

·

2 min read

·

Tristan Manalac

Business negotiation and cooperation vector concept. Symbol of a deal, handshake, success. Minimal design eps10 illustration.

Deals

Boehringer Links with Irish Drug Delivery Start-Up Re-Vana in $1B+ Eye Deal

The German giant is looking to develop new drugs for undisclosed eye diseases using Re-Vana’s extended-release injectable platform to supply drugs to the eye for months at a time.

July 28, 2025

·

1 min read

·

Dan Samorodnitsky

female hand hold human brain on yellow background.

Alzheimer’s disease

Roche’s Next-Gen Alzheimer’s Antibody Clears or Reduces Amyloid Plaques in Seven Months

In a Phase Ib/IIa trial, 91% of patients receiving the highest dose of trontinemab were amyloid negative after seven months of treatment, representing what B. Riley Securities called a “paradigm shift” to first-generation FDA-approved antibodies.

July 28, 2025

·

2 min read

·

Dan Samorodnitsky

Planning strategy and ways to achieve business goals, searching for new opportunities for high results, direction of career development, the path to great success, man changes direction on signpost.

Gene therapy

FDA Does 180 on Sarepta, Freeing DMD Gene Therapy for Ambulatory Patients

The swift FDA action removes an overhang from Sarepta and allows Elevidys to return to the market without another safety study, as had been feared, Jefferies analysts said Monday.

July 28, 2025

·

2 min read

·

Annalee Armstrong